Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Strides Pharma Science Dividend Announcement
• Strides Pharma Science announced a annually dividend of ₹2.50 per ordinary share which will be made payable on 2024-10-25. Ex dividend date: 2024-09-09
• Strides Pharma Science annual dividend for 2024 was ₹2.50
• Strides Pharma Science annual dividend for 2023 was ₹1.50
• Strides Pharma Science's trailing twelve-month (TTM) dividend yield is 0.18%
Strides Pharma Science Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-09 | ₹2.50 | annually | 2024-10-25 |
2023-08-04 | ₹1.50 | annually | 2023-09-27 |
2021-08-05 | ₹2.50 | annually | 2021-10-03 |
2020-07-24 | ₹2.00 | annually | 2020-09-19 |
2019-08-22 | ₹12.00 | annually | 2019-08-27 |
2019-07-19 | ₹3.00 | annually | 2019-08-29 |
2018-09-12 | ₹2.00 | annually | 2018-10-24 |
2017-09-07 | ₹4.50 | annually | 2017-10-15 |
2016-07-21 | ₹4.00 | annually | 2016-08-27 |
2015-07-22 | ₹3.00 | annually | 2015-08-30 |
2014-10-16 | ₹105.00 | annually | 2015-02-01 |
2014-09-01 | ₹5.00 | annually | 2014-10-30 |
2013-12-19 | ₹500.00 | annually | 2014-02-01 |
2013-05-30 | ₹2.00 | annually | 2013-06-05 |
2012-05-14 | ₹2.00 | annually | 2012-05-30 |
Strides Pharma Science Dividend per year
Strides Pharma Science Dividend growth
Strides Pharma Science Dividend Yield
Strides Pharma Science current trailing twelve-month (TTM) dividend yield is 0.18%. Interested in purchasing Strides Pharma Science stock? Use our calculator to estimate your expected dividend yield:
Strides Pharma Science Financial Ratios
Strides Pharma Science Dividend FAQ
Other factors to consider when evaluating Strides Pharma Science as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Strides Pharma Science stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Strides Pharma Science's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Strides Pharma Science publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Strides Pharma Science distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Strides Pharma Science are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Strides Pharma Science sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Strides Pharma Science distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Strides Pharma Science declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Strides Pharma Science's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Strides Pharma Science's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.